Clinical Trial Update: Potential Efficacy and Safety of Using Adjunctive Ibuprofen for XDR-TB Tuberculosis [Phase 2]

View source ↗

Summary

Phase 2 trial assessing adjunctive ibuprofen for efficacy and safety in XDR-TB tuberculosis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Fundació Institut Germans Trias i Pujol | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED